Professor Kyle Hoehn

Kyle is a Professor of Biotechnology at the University of New South Wales. He earned his PhD in Biochemistry from Colorado State University in 2005 where he investigated mechanisms of insulin resistance in adipocytes and hibernating marmots with Prof Scott Summers. Kyle then pursued postdoctoral training at the Garvan Institute with Prof David James from 2005-2009 where he studied cell and mouse models of obesity and insulin resistance. Kyle established his independent lab at the University of Virginia in 2009 where he worked as an Assistant Professor of Pharmacology for 5 years before moving to the University of New South Wales in 2014. Kyle’s lab focuses on developing safe, selective, and self-limiting mitochondrial uncouplers as therapeutics for metabolic disorders.